Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis
暂无分享,去创建一个
E. Ferrero | B. Cenni | Joëlle Rubert | F. Bornancin | Paul Smith | C. Huck | Sarah Tisserand | Cindy Schmid | B. Nuesslein‐Hildesheim | Denis Eichlisberger